2024-01-012024-12-312024-12-31false11076848BREATHEOX LIMITED2025-01-3186900falseiso4217:GBPxbrli:pure110768482024-01-01110768482024-12-31110768482024-01-012024-12-31110768482023-01-01110768482023-12-31110768482023-01-012023-12-3111076848bus:SmallEntities2024-01-012024-12-3111076848bus:AuditExempt-NoAccountantsReport2024-01-012024-12-3111076848bus:FullAccounts2024-01-012024-12-3111076848bus:PrivateLimitedCompanyLtd2024-01-012024-12-3111076848core:WithinOneYear2024-12-3111076848core:AfterOneYear2024-12-3111076848core:WithinOneYear2023-12-3111076848core:AfterOneYear2023-12-3111076848core:ShareCapital2024-12-3111076848core:SharePremium2024-12-3111076848core:RevaluationReserve2024-12-3111076848core:OtherReservesSubtotal2024-12-3111076848core:RetainedEarningsAccumulatedLosses2024-12-3111076848core:ShareCapital2023-12-3111076848core:SharePremium2023-12-3111076848core:RevaluationReserve2023-12-3111076848core:OtherReservesSubtotal2023-12-3111076848core:RetainedEarningsAccumulatedLosses2023-12-3111076848core:LandBuildings2024-12-3111076848core:PlantMachinery2024-12-3111076848core:Vehicles2024-12-3111076848core:FurnitureFittings2024-12-3111076848core:OfficeEquipment2024-12-3111076848core:NetGoodwill2024-12-3111076848core:IntangibleAssetsOtherThanGoodwill2024-12-3111076848core:ListedExchangeTraded2024-12-3111076848core:UnlistedNon-exchangeTraded2024-12-3111076848core:LandBuildings2023-12-3111076848core:PlantMachinery2023-12-3111076848core:Vehicles2023-12-3111076848core:FurnitureFittings2023-12-3111076848core:OfficeEquipment2023-12-3111076848core:NetGoodwill2023-12-3111076848core:IntangibleAssetsOtherThanGoodwill2023-12-3111076848core:ListedExchangeTraded2023-12-3111076848core:UnlistedNon-exchangeTraded2023-12-3111076848core:LandBuildings2024-01-012024-12-3111076848core:PlantMachinery2024-01-012024-12-3111076848core:Vehicles2024-01-012024-12-3111076848core:FurnitureFittings2024-01-012024-12-3111076848core:OfficeEquipment2024-01-012024-12-3111076848core:NetGoodwill2024-01-012024-12-3111076848core:IntangibleAssetsOtherThanGoodwill2024-01-012024-12-3111076848core:ListedExchangeTraded2024-01-012024-12-3111076848core:UnlistedNon-exchangeTraded2024-01-012024-12-3111076848core:MoreThanFiveYears2024-01-012024-12-3111076848core:Non-currentFinancialInstruments2024-12-3111076848core:Non-currentFinancialInstruments2023-12-3111076848dpl:CostSales2024-01-012024-12-3111076848dpl:DistributionCosts2024-01-012024-12-3111076848core:LandBuildings2024-01-012024-12-3111076848core:PlantMachinery2024-01-012024-12-3111076848core:Vehicles2024-01-012024-12-3111076848core:FurnitureFittings2024-01-012024-12-3111076848core:OfficeEquipment2024-01-012024-12-3111076848dpl:AdministrativeExpenses2024-01-012024-12-3111076848core:NetGoodwill2024-01-012024-12-3111076848core:IntangibleAssetsOtherThanGoodwill2024-01-012024-12-3111076848dpl:GroupUndertakings2024-01-012024-12-3111076848dpl:ParticipatingInterests2024-01-012024-12-3111076848dpl:GroupUndertakingscore:ListedExchangeTraded2024-01-012024-12-3111076848core:ListedExchangeTraded2024-01-012024-12-3111076848dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-01-012024-12-3111076848core:UnlistedNon-exchangeTraded2024-01-012024-12-3111076848dpl:CostSales2023-01-012023-12-3111076848dpl:DistributionCosts2023-01-012023-12-3111076848core:LandBuildings2023-01-012023-12-3111076848core:PlantMachinery2023-01-012023-12-3111076848core:Vehicles2023-01-012023-12-3111076848core:FurnitureFittings2023-01-012023-12-3111076848core:OfficeEquipment2023-01-012023-12-3111076848dpl:AdministrativeExpenses2023-01-012023-12-3111076848core:NetGoodwill2023-01-012023-12-3111076848core:IntangibleAssetsOtherThanGoodwill2023-01-012023-12-3111076848dpl:GroupUndertakings2023-01-012023-12-3111076848dpl:ParticipatingInterests2023-01-012023-12-3111076848dpl:GroupUndertakingscore:ListedExchangeTraded2023-01-012023-12-3111076848core:ListedExchangeTraded2023-01-012023-12-3111076848dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-01-012023-12-3111076848core:UnlistedNon-exchangeTraded2023-01-012023-12-3111076848core:NetGoodwill2024-12-3111076848core:IntangibleAssetsOtherThanGoodwill2024-12-3111076848core:LandBuildings2024-12-3111076848core:PlantMachinery2024-12-3111076848core:Vehicles2024-12-3111076848core:FurnitureFittings2024-12-3111076848core:OfficeEquipment2024-12-3111076848core:AfterOneYear2024-12-3111076848core:WithinOneYear2024-12-3111076848core:ListedExchangeTraded2024-12-3111076848core:UnlistedNon-exchangeTraded2024-12-3111076848core:ShareCapital2024-12-3111076848core:SharePremium2024-12-3111076848core:RevaluationReserve2024-12-3111076848core:OtherReservesSubtotal2024-12-3111076848core:RetainedEarningsAccumulatedLosses2024-12-3111076848core:NetGoodwill2023-12-3111076848core:IntangibleAssetsOtherThanGoodwill2023-12-3111076848core:LandBuildings2023-12-3111076848core:PlantMachinery2023-12-3111076848core:Vehicles2023-12-3111076848core:FurnitureFittings2023-12-3111076848core:OfficeEquipment2023-12-3111076848core:AfterOneYear2023-12-3111076848core:WithinOneYear2023-12-3111076848core:ListedExchangeTraded2023-12-3111076848core:UnlistedNon-exchangeTraded2023-12-3111076848core:ShareCapital2023-12-3111076848core:SharePremium2023-12-3111076848core:RevaluationReserve2023-12-3111076848core:OtherReservesSubtotal2023-12-3111076848core:RetainedEarningsAccumulatedLosses2023-12-3111076848core:NetGoodwill2023-01-0111076848core:IntangibleAssetsOtherThanGoodwill2023-01-0111076848core:LandBuildings2023-01-0111076848core:PlantMachinery2023-01-0111076848core:Vehicles2023-01-0111076848core:FurnitureFittings2023-01-0111076848core:OfficeEquipment2023-01-0111076848core:AfterOneYear2023-01-0111076848core:WithinOneYear2023-01-0111076848core:ListedExchangeTraded2023-01-0111076848core:UnlistedNon-exchangeTraded2023-01-0111076848core:ShareCapital2023-01-0111076848core:SharePremium2023-01-0111076848core:RevaluationReserve2023-01-0111076848core:OtherReservesSubtotal2023-01-0111076848core:RetainedEarningsAccumulatedLosses2023-01-0111076848core:AfterOneYear2024-01-012024-12-3111076848core:WithinOneYear2024-01-012024-12-3111076848core:Non-currentFinancialInstrumentscore:CostValuation2024-01-012024-12-3111076848core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-01-012024-12-3111076848core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-01-012024-12-3111076848core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-01-012024-12-3111076848core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-01-012024-12-3111076848core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-01-012024-12-3111076848core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-01-012024-12-3111076848core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-01-012024-12-3111076848core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-01-012024-12-3111076848core:Non-currentFinancialInstrumentscore:CostValuation2024-12-3111076848core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-12-3111076848core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-12-3111076848core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-12-3111076848core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-12-3111076848core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-12-3111076848core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-12-3111076848core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-12-3111076848core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-12-3111076848core:Non-currentFinancialInstrumentscore:CostValuation2023-12-3111076848core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-12-3111076848core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-12-3111076848core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-12-3111076848core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-12-3111076848core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-12-3111076848core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-12-3111076848core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-12-3111076848core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-12-3111076848bus:Director12024-01-012024-12-3111076848bus:Director22024-01-012024-12-3111076848bus:Director32024-01-012024-12-31

BREATHEOX LIMITED

Registered Number
11076848
(England and Wales)

Unaudited Financial Statements for the Year ended
31 December 2024

BREATHEOX LIMITED
Company Information
for the year from 1 January 2024 to 31 December 2024

Directors

DO, Il Hoon William
REISNER, Colin, Doctor
UDANI, Mikesh

Registered Address

9400 Garsington Road
Oxford Business Park
Oxford
OX4 2HN

Registered Number

11076848 (England and Wales)
BREATHEOX LIMITED
Balance Sheet as at
31 December 2024

Notes

2024

2023

£

£

£

£

Fixed assets
Tangible assets3106,1397,155
106,1397,155
Current assets
Debtors4230,230346,494
Cash at bank and on hand217,203871,996
447,4331,218,490
Creditors amounts falling due within one year5(295,038)(201,887)
Net current assets (liabilities)152,3951,016,603
Total assets less current liabilities258,5341,023,758
Net assets258,5341,023,758
Capital and reserves
Called up share capital4,3184,190
Share premium2,801,2072,588,855
Other reserves84,88259,538
Profit and loss account(2,631,873)(1,628,825)
Shareholders' funds258,5341,023,758
The financial statements were approved and authorised for issue by the Board of Directors on 31 January 2025, and are signed on its behalf by:
UDANI, Mikesh
Director
Registered Company No. 11076848
BREATHEOX LIMITED
Notes to the Financial Statements
for the year ended 31 December 2024

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the financial reporting standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Going concern
The directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. The company therefore continues to adopt the going concern basis of accounting in preparing its financial statements.
Revenue from sale of goods
Revenue from the sale of goods is recognised when the company has transferred to the buyer the significant risks and rewards of ownership of the goods, usually when goods are delivered and legal title has passed. Providing the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the company and the costs incurred or to be incurred in respect of the transition can be measured reliably.
Share-based payments
The company provides share-based payment arrangements to certain employees. Equity-settled arrangements are measured at fair value (excluding the effect of non-market based vesting conditions) at the date of the grant. The fair value is expensed on a straightline basis over the vesting period. The amount recognised as an expense is adjusted to reflect the actual number of shares or options that will vest.
Research and development
All research costs are expensed. Costs related to the development of products are capitalised when they meet the criteria stated in FRS 102, Section 18 Intangible assets other than Goodwill. All other development expenditure is recognised as an expense in the period in which it is incurred.
Tangible fixed assets and depreciation
Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

Straight line (years)
Plant and machinery3
2.Average number of employees

20242023
Average number of employees during the year1111
3.Tangible fixed assets

Plant & machinery

Total

££
Cost or valuation
At 01 January 2427,08327,083
Additions110,000110,000
At 31 December 24137,083137,083
Depreciation and impairment
At 01 January 2419,92819,928
Charge for year11,01611,016
At 31 December 2430,94430,944
Net book value
At 31 December 24106,139106,139
At 31 December 237,1557,155
4.Debtors: amounts due within one year

2024

2023

££
Trade debtors / trade receivables12,274-
Other debtors216,387345,016
Prepayments and accrued income1,5691,478
Total230,230346,494
5.Creditors: amounts due within one year

2024

2023

££
Trade creditors / trade payables15,71749,328
Taxation and social security37,78760,107
Other creditors2,82862,049
Accrued liabilities and deferred income238,70630,403
Total295,038201,887